Trinity Biotech (TRIB) Change in Working Capital (2009 - 2022)

Trinity Biotech (TRIB) has reported Change in Working Capital for 14 consecutive years, with $175000.0 the latest figure, recorded in Q4 2022.

• Quarterly Change in Working Capital fell 97.33% year-over-year to $175000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $3.3 million (down 5.9% YoY) and the FY2025 annual result came in at -$186000.0, changed N/A from the prior year.
• Change in Working Capital improved to $175000.0 in Q4 2022 per TRIB's latest filing, from -$2.2 million in the prior quarter.
• Over the last five years, Change in Working Capital for TRIB reached as high as $10.2 million in Q4 2020 and fell as low as -$3.2 million in Q2 2021.
• A 5-year average of -$29105.3 and a median of -$1.3 million in 2022 frame the typical range for Change in Working Capital.
• Annual changes were most pronounced in 2020 — Change in Working Capital surged 3266.36% — and 2021, when it plunged 314.48%.
• Year by year, Change in Working Capital stood at -$2.9 million in 2018, then soared by 89.08% to -$321000.0 in 2019, then jumped by 3266.36% to $10.2 million in 2020, then plunged by 35.47% to $6.6 million in 2021, then slumped by 97.33% to $175000.0 in 2022.
• According to Business Quant data, Change in Working Capital over the past three periods registered $175000.0, -$2.2 million, and -$1.3 million for Q4 2022, Q2 2022, and Q1 2022 respectively.